V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016010 | 260008055 | 1.81 | 52.6 | Curative (C) | 2017-06-03 | 2017-07-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260025022 | BENDAMUSTINE + RITUXIMAB |
| 260016011 | 260008056 | 1.78 | 93 | Curative (C) | 2014-01-23 | 2014-03-13 | BEP 3 day | N | N | 260025031 | BEP |
| 260016012 | 260008057 | 1.78 | 79.1 | Curative (C) | null | 2015-10-06 | BEP 3 day | null | Y | 260025033 | BEP |
| 260016013 | 260016571 | 1.76 | 103.4 | Disease modification (D) | 2014-05-21 | 2014-05-31 | BEP 5 Day | N | N | 260025033 | BEP |
| 260016014 | 260017969 | null | 82.6 | Curative (C) | 2014-12-17 | 2016-06-24 | BEP 3 day | 02 | null | 260025050 | BEP |
| 260016015 | 260008060 | 1.64 | 89.1 | Curative (C) | 2016-09-20 | 2016-09-20 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025050 | BENDAMUSTINE + RITUXIMAB |
| 260016016 | 260008062 | 0 | 85.5 | Curative (C) | 2014-03-12 | 2014-04-22 | Bendamustine+Rituximab (1st Course) | 2 | N | 260025072 | BENDAMUSTINE + RITUXIMAB |
| 260016017 | 260008064 | 1.76 | 72 | Palliative (P) | 2018-04-17 | 2018-05-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260025075 | BENDAMUSTINE + RITUXIMAB |
| 260016018 | 260008064 | 1.7 | 97.8 | Curative (C) | 2015-08-16 | 2015-10-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260025075 | BENDAMUSTINE + RITUXIMAB |
| 260016019 | 260008066 | 1.85 | null | Disease modification (D) | 2015-03-05 | 2015-04-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260025083 | BENDAMUSTINE + RITUXIMAB |
| 260016020 | 260008069 | 1.71 | null | null | 2013-08-06 | 2013-08-06 | BEP 5 Day | 02 | N | 260025085 | BEP |
| 260016021 | 260008073 | 1.79 | 74.1 | Curative (C) | 2018-09-24 | 2018-10-04 | BEP 3 day | N | N | 260025100 | BEP |
| 260016022 | 260008073 | null | null | Curative (C) | 2019-03-27 | 2019-05-30 | BEP 5 Day | N | null | 260025100 | BEP |
| 260016023 | 260016584 | 1.64 | 72.8 | Palliative (P) | 2018-01-06 | 2018-01-18 | BEP 3 day | 02 | N | 260025110 | BEP |
| 260016025 | 260008078 | 1.68 | 117.6 | Disease modification (D) | 2016-02-03 | 2016-04-02 | BENDAMUSTINE + RITUXIMAB | N | N | 260025118 | BENDAMUSTINE + RITUXIMAB |
| 260016026 | 260016586 | 1.6 | 83 | Palliative (P) | 2017-10-02 | 2017-12-22 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025118 | BENDAMUSTINE + RITUXIMAB |
| 260016027 | 260017975 | null | 69.1 | Palliative (P) | 2016-07-12 | 2016-07-26 | BENDAMUSTINE + RITUXIMAB | N | Y | 260025127 | BENDAMUSTINE + RITUXIMAB |
| 260016028 | 260013781 | 1.71 | 95.25 | Disease modification (D) | 2013-09-08 | 2013-11-26 | BENDAMUSTINE + RITUXIMAB | N | N | 260025130 | BENDAMUSTINE + RITUXIMAB |
| 260016029 | 260013782 | 1.69 | 61.2 | null | 2015-02-14 | 2015-03-14 | BEP 3 day | N | N | 260025134 | BEP |
| 260016030 | 260008086 | 1.58 | 62.2 | Curative (C) | 2014-07-24 | 2014-07-29 | BEP 3 day | 02 | N | 260025164 | BEP |
| 260016031 | 260008089 | 1.85 | 70 | Curative (C) | 2017-11-26 | 2018-01-20 | BEP 3 day | 2 | null | 260025170 | BEP |
| 260016032 | 260008089 | 1.79 | 77.4 | Not known (9) | 2015-04-17 | 2015-07-09 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025170 | BENDAMUSTINE + RITUXIMAB |
| 260016033 | 260008091 | 0 | 107 | Adjuvant (A) | 2017-04-29 | 2017-06-03 | BENDAMUSTINE + RITUXIMAB | N | N | 260025179 | BENDAMUSTINE + RITUXIMAB |
| 260016034 | 260013787 | null | 52.6 | Curative (C) | null | 2017-08-30 | Bendamustine+Rituximab(Sub Courses) | N | null | 260025180 | BENDAMUSTINE + RITUXIMAB |
| 260016035 | 260008092 | 1.76 | 82.7 | Disease modification (D) | 2017-05-19 | 2017-05-19 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025180 | BENDAMUSTINE + RITUXIMAB |
| 260016036 | 260008095 | 1.71 | 74 | Curative (C) | 2013-10-28 | 2014-01-17 | BEP 3 day | N | N | 260025182 | BEP |
| 260016037 | 260013791 | 1.8 | 85.7 | Curative (C) | 2015-10-11 | 2015-10-27 | BEP 5 Day | 02 | N | 260025186 | BEP |
| 260016038 | 260008098 | 1.95 | 82.4 | Curative (C) | 2015-09-07 | 2015-12-28 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260025194 | BENDAMUSTINE + RITUXIMAB |
| 260016039 | 260008099 | 1.75 | 76.7 | Not known (9) | 2018-09-12 | 2018-09-12 | BEP 3 day | N | N | 260025200 | BEP |
| 260016040 | 260008099 | 1.61 | 76 | Curative (C) | 2013-05-06 | 2013-05-14 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025200 | BENDAMUSTINE + RITUXIMAB |
| 260016041 | 260013794 | 1.59 | 61.6 | Curative (C) | 2019-01-12 | 2019-02-07 | Bendamustine+Rituximab (1st Course) | null | null | 260025204 | BENDAMUSTINE + RITUXIMAB |
| 260016042 | 260008102 | 1.83 | 83 | Palliative (P) | 2015-11-05 | 2015-11-12 | BEP 3 day | 02 | N | 260025205 | BEP |
| 260016043 | 260008102 | 1.59 | 64.1 | Disease modification (D) | 2017-10-07 | 2017-10-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260025205 | BENDAMUSTINE + RITUXIMAB |
| 260016044 | 260008103 | 1.82 | 101.7 | Adjuvant (A) | 2014-03-08 | 2014-03-19 | BEP 5 Day | N | N | 260025214 | BEP |
| 260016045 | 260008106 | 1.89 | 83 | Curative (C) | 2018-08-11 | 2018-09-02 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260025218 | BENDAMUSTINE + RITUXIMAB |
| 260016046 | 260008107 | null | null | Curative (C) | 2015-06-22 | 2015-09-09 | BENDAMUSTINE + RITUXIMAB | null | null | 260025221 | BENDAMUSTINE + RITUXIMAB |
| 260016047 | 260008109 | 1.85 | 83 | null | 2013-07-11 | 2013-07-11 | BEP 3 day | 02 | N | 260025223 | BEP |
| 260016048 | 260008110 | 1.59 | 70.5 | Curative (C) | 2017-01-06 | 2017-01-12 | BEP 5 Day | 02 | N | 260025232 | BEP |
| 260016049 | 260008111 | null | 76.1 | Not known (9) | 2017-03-14 | 2017-03-15 | BENDAMUSTINE + RITUXIMAB | null | null | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260016050 | 260008111 | 1.7 | 74.8 | Curative (C) | 2016-04-05 | 2016-04-11 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025234 | BENDAMUSTINE + RITUXIMAB |
| 260016051 | 260008112 | 1.79 | 69 | Curative (C) | 2016-08-28 | 2016-10-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025240 | BENDAMUSTINE + RITUXIMAB |
| 260016052 | 260008114 | 1.88 | null | null | 2017-01-16 | 2017-01-30 | BEP 3 day | N | null | 260025259 | BEP |
| 260016053 | 260008115 | 1.75 | 70 | Palliative (P) | 2017-02-19 | 2017-02-20 | BEP 3 day | 02 | N | 260025261 | BEP |
| 260016054 | 260008116 | 1.84 | 51.8 | null | null | 2016-09-12 | Bendamustine+Rituximab (1st Course) | N | N | 260025263 | BENDAMUSTINE + RITUXIMAB |
| 260016055 | 260008117 | 1.75 | 89.6 | Disease modification (D) | 2015-09-18 | 2015-09-23 | BENDAMUSTINE + RITUXIMAB | N | N | 260025263 | BENDAMUSTINE + RITUXIMAB |
| 260016056 | 260013808 | 1.79 | 46 | Curative (C) | 2015-08-04 | 2015-10-08 | BEP 3 day | N | N | 260025266 | BEP |
| 260016057 | 260013809 | 1.53 | 86 | null | 2013-08-24 | 2013-09-15 | BEP 5 Day | 02 | N | 260025268 | BEP |
| 260016058 | 260017988 | 1.91 | 65.3 | Palliative (P) | 2014-06-04 | 2014-07-16 | BEP 3 day | N | N | 260025269 | BEP |
| 260016059 | 260013811 | 1.62 | 76 | Palliative (P) | 2014-04-11 | 2014-04-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260025278 | BENDAMUSTINE + RITUXIMAB |
| 260016060 | 260008125 | 0 | 87 | Curative (C) | 2014-12-27 | 2014-12-30 | BEP 5 Day | N | N | 260025283 | BEP |